ES2553091T3 - Nuevos portadores recubiertos de agentes activos de liberación controlada - Google Patents

Nuevos portadores recubiertos de agentes activos de liberación controlada Download PDF

Info

Publication number
ES2553091T3
ES2553091T3 ES12781346.7T ES12781346T ES2553091T3 ES 2553091 T3 ES2553091 T3 ES 2553091T3 ES 12781346 T ES12781346 T ES 12781346T ES 2553091 T3 ES2553091 T3 ES 2553091T3
Authority
ES
Spain
Prior art keywords
controlled release
natural
release agents
calcium carbonate
synthetic calcium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES12781346.7T
Other languages
English (en)
Spanish (es)
Inventor
Patrick Schwarzentruber
Nicola Di Maiuta
Joachim Schoelkopf
Catherine Jean Ridgway
Patrick A.C. Gane
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Omya International AG
Original Assignee
Omya International AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=47143128&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2553091(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from EP11188597.6A external-priority patent/EP2591772B1/en
Application filed by Omya International AG filed Critical Omya International AG
Application granted granted Critical
Publication of ES2553091T3 publication Critical patent/ES2553091T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/38Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816Wall or shell material
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N25/00Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
    • A01N25/26Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests in coated particulate form
    • A01N25/28Microcapsules or nanocapsules
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425Thiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38Cellulose; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/2833Organic macromolecular compounds
    • A61K9/286Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4833Encapsulating processes; Filling of capsules
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005Wall or coating material
    • A61K9/5021Organic macromolecular compounds
    • A61K9/5036Polysaccharides, e.g. gums, alginate; Cyclodextrin
    • A61K9/5042Cellulose; Cellulose derivatives, e.g. phthalate or acetate succinate esters of hydroxypropyl methylcellulose
    • A61K9/5047Cellulose ethers containing no ester groups, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Dentistry (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Toxicology (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
ES12781346.7T 2011-11-10 2012-11-08 Nuevos portadores recubiertos de agentes activos de liberación controlada Active ES2553091T3 (es)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP11188597.6A EP2591772B1 (en) 2011-11-10 2011-11-10 New coated controlled release active agent carriers
EP11188597 2011-11-10
US201161559253P 2011-11-14 2011-11-14
US201161559253P 2011-11-14
PCT/EP2012/072161 WO2013068478A1 (en) 2011-11-10 2012-11-08 New coated controlled release active agent carriers

Publications (1)

Publication Number Publication Date
ES2553091T3 true ES2553091T3 (es) 2015-12-04

Family

ID=47143128

Family Applications (1)

Application Number Title Priority Date Filing Date
ES12781346.7T Active ES2553091T3 (es) 2011-11-10 2012-11-08 Nuevos portadores recubiertos de agentes activos de liberación controlada

Country Status (25)

Country Link
US (1) US9579291B2 (enExample)
EP (1) EP2747752B1 (enExample)
KR (1) KR101612655B1 (enExample)
CN (1) CN103957893B (enExample)
AU (1) AU2012334082B2 (enExample)
BR (1) BR112014011310B1 (enExample)
CA (1) CA2851069C (enExample)
CL (1) CL2014001172A1 (enExample)
CO (1) CO6940430A2 (enExample)
DK (1) DK2747752T3 (enExample)
ES (1) ES2553091T3 (enExample)
IL (1) IL231959A0 (enExample)
IN (1) IN2014MN00843A (enExample)
MX (1) MX346884B (enExample)
MY (1) MY168425A (enExample)
PH (1) PH12014500750A1 (enExample)
PL (1) PL2747752T3 (enExample)
PT (1) PT2747752E (enExample)
RU (2) RU2665382C1 (enExample)
SG (1) SG11201401350WA (enExample)
SI (1) SI2747752T1 (enExample)
SM (1) SMT201600010B (enExample)
TW (1) TWI625129B (enExample)
WO (1) WO2013068478A1 (enExample)
ZA (1) ZA201403611B (enExample)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUE025008T2 (en) 2012-10-12 2016-04-28 Omya Int Ag Gastro-reactive pharmaceutical composition and delivery systems and method for their preparation using functionalized calcium carbonate
EP2956005A4 (en) * 2013-02-15 2016-08-24 Wellmark Internat FORMULATION FOR MINERAL ANIMAL FEEDING
EP3103844B1 (en) * 2015-06-10 2018-08-08 Omya International AG Use of surface-reacted calcium carbonate as anti-blocking agent
EP3176222A1 (en) * 2015-12-01 2017-06-07 Omya International AG Method for the production of granules comprising surface-reacted calcium carbonate
CA3016464A1 (en) 2016-03-08 2017-09-14 Soo-Young Kang Long lasting cosmetic compositions
EP3275947A1 (en) * 2016-07-25 2018-01-31 Omya International AG Surface-reacted calcium carbonate with functional cations
EP3400810A1 (en) * 2017-05-11 2018-11-14 Omya International AG Surface-reacted calcium carbonate in food
CN107258776A (zh) * 2017-06-29 2017-10-20 山东大农药业有限公司 一种缓释农药颗粒剂及其制备方法
CA3074845A1 (en) 2017-09-13 2019-03-21 Living Proof, Inc. Color protectant compositions
JP7244495B2 (ja) 2017-09-13 2023-03-22 リビング プルーフ インコーポレイテッド 長期持続性の化粧品組成物
EP3694491A1 (en) 2017-10-10 2020-08-19 Capsugel Belgium NV Gelling multiparticulates
WO2019099966A1 (en) 2017-11-20 2019-05-23 Living Proof, Inc. Properties for achieving long-lasting cosmetic performance
EP3520798A1 (en) * 2018-01-31 2019-08-07 Omya International AG Use of functionalized calcium carbonate as active ingredient
AU2019257739B2 (en) 2018-04-27 2025-01-09 Living Proof, Inc. Long lasting cosmetic compositions
EP3598105A1 (en) 2018-07-20 2020-01-22 Omya International AG Method for detecting phosphate and/or sulphate salts on the surface of a substrate or within a substrate, use of a lwir detecting device and a lwir imaging system
US11896685B2 (en) 2018-10-31 2024-02-13 Amorepacific Corporation Core-shell network structure comprising biopolymer and composition comprising same
KR102739456B1 (ko) * 2018-10-31 2024-12-09 (주)아모레퍼시픽 바이오 폴리머를 포함하는 코어-쉘 네트워크 구조체 및 이를 포함하는 조성물
US20220105047A1 (en) * 2019-01-16 2022-04-07 Research Cooperation Foundation Of Yeungnam University Microcapsule composition using alginate gel, and method for producing same
KR20210069344A (ko) 2019-12-03 2021-06-11 (주)아모레퍼시픽 바이오 폴리머를 포함하는 효능물질 전달체
CN111436426B (zh) * 2020-05-11 2022-04-08 北京首创股份有限公司 供水管道输水用二次加氯胶囊及其制备方法
EP3928859A1 (en) * 2020-06-23 2021-12-29 Omya International AG Surface-reacted calcium carbonate in a process for the production of a loaded microcapsule
AR123009A1 (es) 2020-07-20 2022-10-19 Omya Int Ag Agente estabilizante para composición probiótica
WO2025132417A1 (en) 2023-12-19 2025-06-26 Omya International Ag Granular material comprising a carboxymethylcellulose binder
WO2025207519A1 (en) * 2024-03-23 2025-10-02 Texas Tech University System Biocompatible and biodegradable polymer nanodiscs as lipoprotein-mimicking nanocarriers with high stability and long circulation time for drug delivery

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2223896A1 (de) 1972-05-17 1973-11-29 Sanol Arznei Schwarz Gmbh Verfahren zum ueberziehen von feinteiligen arzneimitteln
US4657784A (en) 1986-03-10 1987-04-14 Ecolab Inc. Process for encapsulating particles with at least two coating layers having different melting points
DE59209706D1 (de) * 1992-12-01 1999-07-08 Spirig Ag S(+)-Ibuprofen enthaltende Arzneimittel
US5958458A (en) * 1994-06-15 1999-09-28 Dumex-Alpharma A/S Pharmaceutical multiple unit particulate formulation in the form of coated cores
FR2787802B1 (fr) 1998-12-24 2001-02-02 Pluss Stauffer Ag Nouvelle charge ou pigment ou mineral traite pour papier, notamment pigment contenant du caco3 naturel, son procede de fabrication, compositions les contenant, et leurs applications
FR2852600B1 (fr) 2003-03-18 2005-06-10 Nouveau pigment mineral contenant du carbonate de calcium, suspension aqueuse le contenant et ses usages
FR2871474B1 (fr) 2004-06-11 2006-09-15 Omya Development Ag Nouveau pigment mineral sec contenant du carbonate de calcium, suspension aqueuse le contenant et ses usages
EP1891937A1 (en) 2006-08-25 2008-02-27 Novartis AG Galenic formulations of aliskiren
SI1974807T1 (sl) * 2007-03-21 2010-06-30 Omya Development Ag Postopek za odstranjevanje motilcev endokrinega sistema
EP2070991B1 (en) 2007-12-12 2010-09-08 Omya Development AG Process to make surface-reacted precipitated calcium carbonate
EP2168572A1 (en) * 2008-09-30 2010-03-31 Omya Development Ag New controlled release active agent carrier
KR20170081748A (ko) 2009-04-24 2017-07-12 옴야 인터내셔널 아게 활성 성분의 방출 조절을 위한 미립자 물질
PT2264109E (pt) 2009-06-15 2012-05-09 Omya Development Ag Processo de preparação de carbonato de cálcio com superfície tratada por reacção e sua utilização
PT2264108E (pt) 2009-06-15 2012-05-23 Omya Development Ag Processo para preparar um carbonato de cálcio feito reagir em superfície utilizando um ácido fraco

Also Published As

Publication number Publication date
PH12014500750A1 (en) 2014-05-12
DK2747752T3 (en) 2016-01-18
RU2665382C1 (ru) 2018-08-29
IL231959A0 (en) 2014-05-28
TW201328709A (zh) 2013-07-16
EP2747752B1 (en) 2015-10-07
SG11201401350WA (en) 2014-05-29
SI2747752T1 (sl) 2015-12-31
CA2851069C (en) 2016-05-31
CN103957893B (zh) 2017-08-15
BR112014011310A2 (pt) 2017-05-09
AU2012334082B2 (en) 2015-10-29
NZ623515A (en) 2016-09-30
RU2018123688A3 (enExample) 2022-01-24
US20140248340A1 (en) 2014-09-04
EP2747752A1 (en) 2014-07-02
MY168425A (en) 2018-11-09
MX2014005466A (es) 2014-08-22
TWI625129B (zh) 2018-06-01
PT2747752E (pt) 2016-02-08
RU2018123688A (ru) 2019-03-07
ZA201403611B (en) 2015-07-29
AU2012334082A1 (en) 2014-04-24
KR101612655B1 (ko) 2016-04-14
CO6940430A2 (es) 2014-05-09
PL2747752T3 (pl) 2016-04-29
US9579291B2 (en) 2017-02-28
CL2014001172A1 (es) 2014-09-12
CA2851069A1 (en) 2013-05-16
SMT201600010B (it) 2016-02-25
MX346884B (es) 2017-04-05
BR112014011310B1 (pt) 2022-04-12
WO2013068478A1 (en) 2013-05-16
CN103957893A (zh) 2014-07-30
KR20140091054A (ko) 2014-07-18
IN2014MN00843A (enExample) 2015-07-03

Similar Documents

Publication Publication Date Title
ES2553091T3 (es) Nuevos portadores recubiertos de agentes activos de liberación controlada
UY32151A (es) Nuevo portador de agentes activos liberados de forma controlada
ES2536206T3 (es) Parche medicinal
TN2014000141A1 (en) New coated controlled release active agent carriers
ES2492497T3 (es) Perácidos alfa-ceto y métodos para su producción y uso
CL2013000163A1 (es) Proceso para la preparacion de material de carbonato de calcio que comprende proveer al menos un material que contenga carbonato de calcio, proveer al menos una sal de un acido graso c5-c28, tratar el material poniendolo en contacto con dicho acido graso y obtener dicho material tratado superficialmente; material de carbonato de calcio; y su uso en el control de material organico en un medio acuoso.
AR093237A1 (es) Indicacion y activacion de conjuntos de parametros para la codificacion de video
MX2012013752A (es) Producto medico con un recubrimiento libre de particulas que libera una sustancia activa.
UY36313A (es) Composición que comprende un carbonato de calcio reaccionado en la superficie como agente antiaglomerante, y método para producirla
CO7350657A2 (es) Formulación de forma de dosificación sólida de desintegración veloz que comprende carbonato de calcio funcionalizado y método para su fabricación
MX340238B (es) Particulas fertilizantes recubiertas.
AR098692A1 (es) Composición de limpieza abrasiva
PH12015502732A1 (en) Personal care articles
CL2008000776A1 (es) Proceso para el control de la deposicion de material pegajoso organico en un medio acuoso, donde se agrega un producto de reaccion de carbonato de calcio natural con dioxido de carbono y uno o mas acidos.
CO6630136A2 (es) Procedimiento para la preparación de 4-{4[({4-cloro-3-(trifluorometil) fenil]amino}carbonil)amino]-3-fluorofenoxi}-n-metilpiridina-2-carbocamida, sus sales y su monohidrato
CO2018001368A2 (es) Métodos para administrar enzimas o microbios productores de carbonato de calcio en el fondo del pozo
AR102207A1 (es) Un método para preparar un filtro de tejido catalizado y un filtro de tejido catalizado
AR079890A1 (es) Estabilizacion de peliculas de oxido de zinc en composiciones bucales
AR085732A1 (es) Un dispositivo generador de 1-metilciclopropano
ES2509116T3 (es) Aceptor de color que reacciona formando color con un precursor de colorante, y material de registro termosensible con un aceptor de color de este tipo
ES2530731T3 (es) Dispositivos médicos que contienen nitroprusiato y agentes antimicrobianos
TW201613561A (en) Composition comprising reduced coenzyme q10
IL287700A (en) Magnesium carbonate is surface backed as a carrier material for the release of one or more active ingredients in a home care formulation
PH12016502536A1 (en) Composite preparation comprising 5-a-reductase inhibitor-containing film coating layer, and method for producing the composite preparation
ES2597030T3 (es) Material compuesto de caucho-cordón de acero